Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]

View source ↗

Summary

This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H mutation, and that r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• CLSP-1025

Snippet

Sponsor: Clasp Therapeutics, Inc. | Conditions: Advanced Solid Tumor, Unresectable Solid Tumor | Phase 1 | Status: RECRUITING